Vanda Pharmaceuticals' GAAP loss for 3 months of 2022 was $6.43 million, compared to a profit of $8.65 million in the previous year. Revenues decreased by 4% to $60.192 mln against $62.669 mln in the previous year.
Vanda Pharmaceuticals' GAAP loss for 3 months of 2022 was $6.43 million, compared to a profit of $8.65 million in the previous year. Revenues decreased by 4% to $60.192 mln against $62.669 mln in the previous year. 
vandapharmaceuticalsinc.gcs-web.com
English (US) 